G-CSF/dexamethasone mobilization of granulocytes modulates changes in expression profile of genes involved in different biological processes
Sequence ID . | Primary sequence name . | Sequence code . | Sequence description . | Fold change . |
---|---|---|---|---|
Transcription and regulation of transcription | ||||
1514893 | CCNA1 | NM_003914 | Cyclin A1 | 21.01 |
1983249 | SMARCA3 | BF513730 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3 | 10.43 |
1513827 | MLXIP | AB020674 | MLX interacting protein | 8.66 |
1519529 | MSL3L1 | NM_078629 | Male-specific lethal 3-like 1 (Drosophila) | 6.75 |
1521872 | MEF2A | NM_005587 | MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A) | 6.47 |
1985292 | ETS2 | BX433326 | V-ets erythroblastosis virus E26 oncogene homolog 2 | 5.59 |
1525013 | BATF | NM_006399 | Basic leucine zipper transcription factor, ATF-like | 5.58 |
1537803 | ENO1 | NM_001428 | Enolase 1, (alpha) | 5.50 |
1533218 | HIPK2 | BC041926 | CDNA clone IMAGE:5300349 | 5.07 |
1522326 | PHTF1 | NM_006608 | Putative homeodomain transcription factor 1 | 4.80 |
1533591 | SIRT5 | NM_012241 | Sirtuin (silent mating type information regulation 2 homolog) 5 (Saccharomyces cerevisiae) | 4.60 |
1512793 | ZNF167 | NM_018651 | Zinc finger protein 167 | 4.30 |
1511846 | PLAG1 | NM_002655 | Pleomorphic adenoma gene 1 | 4.26 |
1512354 | ZNF438 | AK095436 | hypothetical protein LOC220929 | 4.20 |
1507417 | DACH1 | NM_080759 | Dachshund homolog 1 (Drosophila) | 4.04 |
1526663 | ZNF438 | NM_182755 | Zinc finger protein 438 | 4.02 |
1537859 | ZBTB20 | NM_015642 | Zinc finger and BTB domain containing 20 | 3.77 |
1522362 | ZNF658 | NM_033160 | Zinc finger protein 658 | 3.75 |
1534837 | ZNF254 | NM_004876 | Zinc finger protein 539 | 3.73 |
1507368 | CCND3 | NM_001760 | Cyclin D3 | 3.69 |
1509049 | VENTX | NM_014468 | VENT homeobox homolog (Xenopus laevis) | 3.61 |
1985753 | CRTC3 | AK090443 | CREB regulated transcription coactivator 3 | 3.58 |
1529278 | XRN2 | NM_012255 | 5′-3′ exoribonuclease 2 | 3.43 |
1522102 | E2F2 | NM_004091 | E2F transcription factor 2 | 3.36 |
1517472 | CCNC | NM_005190 | Cyclin C | 3.07 |
1535521 | KLF6 | U51869 | Kruppel-like factor 6 | 3.03 |
1537902 | TSC22D1 | NM_183422 | TSC22 domain family, member 1 | −3.01 |
1983175 | MCM7 | NM_182776 | MCM7 minichromosome maintenance deficient | −3.02 |
1529350 | SSRP1 | NM_003146 | Structure specific recognition protein 1 | −3.03 |
1505187 | RELB | NM_006509 | V-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (avian) | −3.04 |
1537144 | DEXI | AK055529 | dexamethasone-induced transcript | −3.07 |
1516882 | MEF2C | NM_002397 | MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) | −3.09 |
1527019 | CHAF1A | NM_005483 | Chromatin assembly factor 1, subunit A (p150) | −3.25 |
1535620 | NCOR2 | NM_006312 | Nuclear receptor co-repressor 2 | −3.34 |
1523857 | ZNF395 | NM_018660 | Zinc finger protein 395 | −3.34 |
1512878 | ZMYND11 | NM_006624 | Zinc finger, MYND domain containing 11 | −3.35 |
1991240 | HMGA1 | NM_145904 | High mobility group AT-hook 1 | −3.37 |
1531990 | HEY1 | NM_012258 | Hairy/enhancer-of-split related with YRPW motif 1 | −3.39 |
1533586 | ELK1 | NM_005229 | ELK1, member of ETS oncogene family | −3.50 |
1515979 | NR4A3 | NM_173199 | Nuclear receptor subfamily 4, group A, member 3 | −3.58 |
1510333 | THRA | NM_003250 | Thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | −3.68 |
1537025 | BTG2 | NM_006763 | BTG family, member 2 | −3.73 |
1513189 | TRERF1 | NM_033502 | Transcriptional regulating factor 1 | −3.76 |
1511905 | JARID2 | NM_004973 | Jumonji, AT-rich interactive domain 2 | −3.81 |
1526826 | ATF3 | NM_004024 | Activating transcription factor 3 | −3.82 |
1523890 | RASSF7 | NM_003475 | Ras association (RalGDS/AF−6) domain family 7 | −3.84 |
1533807 | MAFF | NM_012323 | V-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | −3.89 |
1525862 | JUN | NM_002228 | V-jun sarcoma virus 17 oncogene homolog (avian) | −3.94 |
1507971 | NRL | NM_006177 | Neural retina leucine zipper | −4.09 |
1533916 | LEF1 | NM_016269 | Lymphoid enhancer-binding factor 1 | −4.22 |
1506607 | ASF1B | NM_018154 | ASF1 antisilencing function 1 homolog B (S cerevisiae) | −4.36 |
1509496 | AES | NM_198969 | Amino-terminal enhancer of split | −4.39 |
1533535 | TAF4 | NM_003185 | TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa | −4.40 |
1508056 | EGR3 | NM_004430 | Early growth response 3 | −4.41 |
1533262 | BRF1 | BC016743 | BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S cerevisiae) | −4.48 |
1533571 | PHF6 | NM_032458 | PHD finger protein 6 | −4.53 |
1517506 | EGR2 | NM_000399 | Early growth response 2 (Krox−20 homolog, Drosophila) | −4.66 |
1989375 | SMAD3 | NM_005902 | SMAD, mothers against DPP homolog 3 (Drosophila) | −4.97 |
1507856 | MYB | NM_005375 | V-myb myeloblastosis viral oncogene homolog (avian) | −5.06 |
1528623 | OLIG2 | NM_005806 | Oligodendrocyte lineage transcription factor 2 | −6.11 |
1524585 | GATA1 | NM_002049 | GATA binding protein 1 (globin transcription factor 1) | −6.64 |
1991493 | PARP14 | NM_017554 | Poly (ADP-ribose) polymerase family, member 14 | −7.03 |
1510055 | PCGF5 | BC007377 | Polycomb group ring finger 5 | −7.57 |
1510369 | ASCL2 | NM_005170 | Achaete-scute complex-like 2 (Drosophila) | −7.72 |
1522208 | ZNF584 | NM_173548 | Zinc finger protein 584 | −7.93 |
1523937 | RPS6KA5 | NM_004755 | Ribosomal protein S6 kinase, 90 kDa, polypeptide 5 | −8.07 |
1529851 | ETV7 | NM_016135 | Ets variant gene 7 (TEL2 oncogene) | −8.56 |
1506298 | GATA6 | NM_005257 | GATA binding protein 6 | −8.65 |
1989096 | SSBP3 | NM_001009955 | Single stranded DNA binding protein 3 | −8.76 |
1520503 | NKX31 | NM_006167 | NK3 transcription factor related, locus 1 (Drosophila) | −9.56 |
1522991 | ZNF649 | NM_023074 | Zinc finger protein 649 | −11.07 |
1514700 | NR4A1 | NM_002135 | Nuclear receptor subfamily 4, group A, member 1 | −92.91 |
Signal transduction | ||||
1513543 | GPR84 | NM_020370 | G protein-coupled receptor 84 | 25.51 |
1505483 | EDG1 | NM_001400 | Endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 | 18.05 |
1511321 | PTGER2 | NM_000956 | Prostaglandin E receptor 2 (subtype EP2), 53 kDa | 8.26 |
1511570 | ARHGAP24 | AK130576 | Rho GTPase activating protein 24 | 7.28 |
1523886 | PDE4D | NM_006203 | Phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) | 6.64 |
1527053 | MYO10 | BC041694 | Myosin X | 6.48 |
1512860 | MS4A4A | NM_024021 | Membrane-spanning 4-domains, subfamily A, member 4 | 6.12 |
1539087 | DLC1 | NM_182643 | Deleted in liver cancer 1 | 5.96 |
1528643 | MS4A6A | NM_022349 | Membrane-spanning 4-domains, subfamily A, member 6A | 5.87 |
1524040 | GPR141 | NM_181791 | G protein-coupled receptor 141 | 5.28 |
1989101 | EDARADD | NM_080738 | EDAR-associated death domain | 4.64 |
1508615 | EXT1 | NM_000127 | Exostoses (multiple) 1 | 4.30 |
1521881 | STK3 | NM_006281 | Serine/threonine kinase 3 (STE20 homolog, yeast) | 3.79 |
1510158 | ITPKC | NM_025194 | Inositol 1.4,5-trisphosphate 3-kinase C | 3.63 |
1519571 | CDC42EP3 | NM_006449 | CDC42 effector protein (Rho GTPase binding) 3 | 3.58 |
1534557 | DPYSL3 | NM_001387 | Dihydropyrimidinase-like 3 | 3.54 |
1536781 | RPS6KA3 | NM_004586 | Ribosomal protein S6 kinase, 90 kDa, polypeptide 3 | 3.53 |
1533999 | HHIP | NM_022475 | Hedgehog interacting protein | 3.50 |
1512578 | GPR97 | NM_170776 | G protein-coupled receptor 97 | 3.42 |
1514738 | SLC26A6 | NM_022911 | Inositol hexaphosphate kinase 2 | 3.28 |
1517434 | IL4R | NM_000418 | Interleukin 4 receptor | 3.21 |
1539209 | GABBR1 | NM_001470 | Gamma-aminobutyric acid (GABA) B receptor, 1 | 3.19 |
1511435 | STK16 | NM_003691 | Serine/threonine kinase 16 | 3.17 |
1520958 | PRKAR2A | BC002763 | Inositol hexaphosphate kinase 2 | 3.12 |
1506387 | MAPK6 | NM_002748 | Mitogen-activated protein kinase 6 | 3.03 |
1523162 | ITPK1 | NM_014216 | Inositol 1.3,4-triphosphate 5/6 kinase | −3.05 |
1507956 | GNGT2 | NM_031498 | Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 | −3.09 |
1514326 | TAGAP | NM_138810 | T-cell activation GTPase activating protein | −3.09 |
1530414 | GPR171 | NM_013308 | G protein-coupled receptor 171 | −3.16 |
1527339 | P2RY5 | NM_005767 | Purinergic receptor P2Y, G-protein coupled, 5 | −3.17 |
1517355 | ARHGAP25 | BC039591 | Rho GTPase activating protein 25 | −3.23 |
1520830 | KIT | NM_000222 | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | −3.28 |
1517660 | KLRK1 | NM_007360 | Killer cell lectin-like receptor subfamily C, member 4 | −3.37 |
1514077 | KLRB1 | NM_002258 | Killer cell lectin-like receptor subfamily B, member 1 | −3.43 |
1518328 | GRP | NM_002091 | Gastrin-releasing peptide | −3.64 |
1516849 | EPHB1 | NM_004441 | EPH receptor B1 | −3.80 |
1514753 | PRKAG2 | NM_016203 | Protein kinase, AMP-activated, gamma 2 non-catalytic subunit | −4.09 |
1512127 | SOCS1 | NM_003745 | Suppressor of cytokine signaling 1 | −4.13 |
1518864 | FLT3LG | NM_001459 | Fms-related tyrosine kinase 3 ligand | −4.26 |
1524915 | OR51E1 | NM_152430 | Olfactory receptor, family 51, subfamily E, member 1 | −4.27 |
1507227 | P2RY14 | NM_014879 | Purinergic receptor P2Y, G-protein coupled, 14 | −4.28 |
1523084 | GUCA1A | NM_000409 | Guanylate cyclase activator 1A (retina) | −4.37 |
1525046 | PILRA | NM_178273 | Paired immunoglobulin-like type 2 receptor alpha | −4.48 |
1534223 | PPP1R12B | NM_032105 | Protein phosphatase 1, regulatory (inhibitor) subunit 12B | −4.66 |
1518048 | GPR34 | NM_005300 | G-protein–coupled receptor 34 | −4.78 |
1534320 | ARRB1 | NM_004041 | Arrestin, beta 1 | −5.02 |
1534974 | KLRD1 | NM_002262 | Killer cell lectin-like receptor subfamily D, member 1 | −5.16 |
1525314 | S100A10 | NM_002966 | S100 calcium binding protein A10 | −5.94 |
1530940 | PRKAR2B | NM_002736 | Protein kinase, cAMP-dependent, regulatory, type II, beta | −5.97 |
1522410 | IL2RB | NM_000878 | Interleukin 2 receptor, beta | −6.06 |
1518652 | CD74 | NM_004355 | CD74 molecule, major histocompatibility complex, class II invariant chain | −6.23 |
1515002 | CYSLTR1 | NM_006639 | Cysteinyl leukotriene receptor 1 | −6.45 |
1530332 | MX1 | NM_002462 | Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | −6.76 |
1522509 | OR2B2 | NM_033057 | Olfactory receptor, family 2, subfamily B, member 2 | −6.88 |
1984459 | PDE4B | AB209081 | Phosphodiesterase 4B, cAMP-specific | −6.89 |
1527378 | CSF1R | NM_005211 | Colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog | −7.08 |
1527858 | NRGN | NM_006176 | Neurogranin (protein kinase C substrate, RC3) | −7.49 |
1524392 | ANGPT1 | NM_001146 | Angiopoietin 1 | −8.84 |
1516837 | MS4A3 | NM_006138 | Membrane-spanning 4-domains, subfamily A, member 3 | −9.24 |
1989999 | IL5RA | NM_175725 | Interleukin 5 receptor, alpha | −9.66 |
1524637 | GPR162 | NM_019858 | Triosephosphate isomerase 1 | −10.10 |
1519217 | P2RY2 | NM_176072 | Purinergic receptor P2Y, G-protein coupled, 2 | −11.66 |
1516830 | P2RY10 | NM_014499 | Purinergic receptor P2Y, G-protein coupled, 10 | −11.67 |
1518123 | CD83 | NM_004233 | CD83 molecule | −11.67 |
1517216 | KLRF1 | NM_016523 | Killer cell lectin-like receptor subfamily F, member 1 | −12.68 |
1512228 | EBI2 | NM_004951 | Epstein-Barr virus–induced gene 2 (lymphocyte-specific G protein-coupled receptor) | −13.11 |
1513158 | HRH4 | NM_021624 | Histamine receptor H4 | −13.66 |
1537338 | FGL2 | NM_006682 | Fibrinogen-like 2 | −13.76 |
1515714 | GNG11 | NM_004126 | Guanine nucleotide binding protein (G protein), gamma 11 | −16.57 |
1527111 | GPR44 | NM_004778 | G protein-coupled receptor 44 | −23.51 |
1528909 | RGS1 | NM_002922 | Regulator of G-protein signaling 1 | −32.65 |
Immune responses | ||||
1507161 | CD163 | NM_004244 | CD163 molecule | 54.27 |
1531927 | CYP1B1 | NM_000104 | Cytochrome P450, family 1, subfamily B, polypeptide 1 | 46.19 |
1984958 | CD177 | CR592446 | CD177 molecule | 24.38 |
1521404 | IL18R1 | NM_003855 | Interleukin 18 receptor 1 | 16.54 |
1983056 | MERTK | U08023 | C-mer proto-oncogene tyrosine kinase | 16.00 |
1532739 | CLEC5A | NM_013252 | C-type lectin domain family 5, member A | 13.44 |
1511835 | CLEC4D | NM_080387 | C-type lectin domain family 4, member D | 12.02 |
1535646 | CST7 | NM_003650 | Cystatin F (leukocystatin) | 11.43 |
1506996 | ADORA3 | NM_020683 | Adenosine A3 receptor | 10.89 |
1530098 | IL18RAP | NM_003853 | Interleukin 18 receptor accessory protein | 10.79 |
1532148 | LAIR1 | NM_021706 | Leukocyte-associated immunoglobulin-like receptor 1 | 10.45 |
1506562 | HP | NM_005143 | Haptoglobin | 10.31 |
1505718 | IL1R2 | NM_004633 | Interleukin 1 receptor, type II | 9.95 |
1507483 | LILRA5 | NM_181879 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | 7.56 |
1524454 | XBP1 | NM_005080 | X-box binding protein 1 | 7.48 |
1510813 | IRAK3 | NM_007199 | Interleukin−1 receptor-associated kinase 3 | 7.28 |
1538778 | TLR5 | NM_003268 | Toll-like receptor 5 | 5.97 |
1521047 | CR1 | NM_000651 | Complement component (3b/4b) receptor 1 (Knops blood group) | 5.87 |
1520792 | MAPK14 | NM_139013 | Mitogen-activated protein kinase 14 | 5.75 |
1535716 | CD59 | NM_203330 | CD59 molecule, complement regulatory protein | 5.67 |
1513648 | FCER1G | CB529629 | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 5.26 |
1521687 | TLR4 | BF670973 | Toll-like receptor 4 | 5.15 |
1530114 | MAP2K6 | NM_002758 | Mitogen-activated protein kinase kinase 6 | 4.87 |
1533789 | SERPINB1 | NM_030666 | Serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 4.84 |
1522193 | FCAR | NM_002000 | Fc fragment of IgA, receptor for | 4.52 |
1527121 | PROK2 | NM_021935 | Prokineticin 2 | 4.33 |
1505831 | CIAS1 | NM_004895 | Cold autoinflammatory syndrome 1 | 4.09 |
1524842 | IL10 | NM_000572 | Interleukin 10 | 3.89 |
1538909 | IL1RAP | NM_002182 | Interleukin 1 receptor accessory protein | 3.80 |
1506853 | CHIT1 | NM_003465 | Chitinase 1 (chitotriosidase) | 3.48 |
1531091 | CD55 | NM_000574 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 3.39 |
1534101 | IL1R1 | NM_000877 | Interleukin 1 receptor, type I | 3.34 |
1515424 | CYBB | S67289 | Cytochrome b-245, beta polypeptide (chronic granulomatous disease) | 3.29 |
1985998 | ALOX5 | BQ548663 | Arachidonate 5-lipoxygenase | 3.16 |
1510372 | IRAK4 | NM_016123 | Interleukin-1 receptor-associated kinase 4 | 3.10 |
1514172 | CD48 | NM_001778 | CD48 molecule | 3.09 |
1527340 | TLR8 | NM_016610 | Toll-like receptor 8 | 3.07 |
1511452 | SERPING1 | NM_000062 | Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary) | −3.00 |
1530131 | IRF2BP2 | BC020516 | Interferon regulatory factor 2 binding protein 2 | −3.03 |
1512742 | CLEC7A | NM_197954 | C-type lectin domain family 7, member A | −3.06 |
1528251 | NCR3 | NM_147130 | Natural cytotoxicity triggering receptor 3 | −3.13 |
1513772 | HLA-DRB3 | NM_022555 | Major histocompatibility complex, class II, DR beta 1 | −3.17 |
1518778 | ALOX15 | NM_001140 | Arachidonate 15-lipoxygenase | −3.24 |
1524640 | OAS3 | NM_006187 | 2'−5'-oligoadenylate synthetase 3, 100 kDa | −3.31 |
1985491 | HLA-DRB1 | X12544 | Major histocompatibility complex, class II, DR beta 1 | −3.31 |
1519302 | STAT1 | NM_139266 | Signal transducer and activator of transcription 1, 91 kDa | −3.39 |
1509654 | CTSW | NM_001335 | Cathepsin W (lymphopain) | −3.45 |
1992017 | PLAUR | NM_001005377 | Plasminogen activator, urokinase receptor | −3.50 |
1526588 | LY75 | NM_002349 | Lymphocyte antigen 75 | −3.51 |
1536508 | LST1 | NM_007161 | Leukocyte specific transcript 1 | −3.64 |
1515890 | FAIM3 | NM_005449 | Interleukin 24 | −3.65 |
1511424 | EMR3 | NM_032571 | Egf-like module containing, mucin-like, hormone receptor-like 3 | −3.71 |
1534340 | CD46 | NM_002389 | CD46 molecule, complement regulatory protein | −3.83 |
1537056 | GBP3 | NM_018284 | Guanylate binding protein 1, interferon-inducible, 67 kDa | −3.86 |
1517555 | CYP27A1 | NM_000784 | Cytochrome P450, family 27, subfamily A, polypeptide 1 | −3.88 |
1516190 | SAMHD1 | NM_015474 | SAM domain and HD domain 1 | −3.89 |
1519488 | HLA-DQB2 | NM_182549 | Major histocompatibility complex, class II, DQ beta 2 | −3.94 |
1983904 | IL32 | NM_001012631 | Interleukin 32 | −3.99 |
1505541 | GZMB | NM_004131 | Granzyme B | −4.04 |
1536691 | GZMK | NM_002104 | Granzyme K (granzyme 3; tryptase II) | −4.67 |
1522713 | GZMA | NM_006144 | Granzyme A | −4.80 |
1510975 | HLA-DRB5 | NM_002125 | Major histocompatibility complex, class II, DR beta 1 | −5.13 |
1527466 | HLA-DPA1 | NM_033554 | Major histocompatibility complex, class II, DP alpha 1 | −5.16 |
1516918 | B2M | AK022379 | Beta−2-microglobulin | −5.43 |
1538818 | HLA-DQB1 | NM_002123 | Major histocompatibility complex, class II, DQ beta 1 | −5.87 |
1521122 | SPON2 | NM_012445 | Spondin 2, extracellular matrix protein | −5.95 |
1517271 | PF4V1 | NM_002620 | Platelet factor 4 variant 1 | −6.48 |
1508682 | HLA-DPB1 | NM_002121 | Major histocompatibility complex, class II, DP beta 1 | −6.67 |
1529151 | OASL | NM_003733 | 2′−5′-oligoadenylate synthetase-like | −7.10 |
1987518 | CYB561 | NM_001017916 | Cytochrome b-561 | −7.39 |
1524314 | IFI44 | NM_006417 | Interferon-induced protein 44 | −7.91 |
1533656 | DEFA4 | NM_001925 | Defensin, alpha 4, corticostatin | −9.04 |
1526794 | HLA-DRA | NM_019111 | Major histocompatibility complex, class II, DR alpha | −10.12 |
1536919 | HLA-DMB | NM_002118 | Major histocompatibility complex, class II, DM beta | −10.73 |
1525510 | PF4 | NM_002619 | Platelet factor 4 (chemokine (C-X-C motif) ligand 4) | −11.03 |
1514544 | DEFA3 | NM_005217 | Defensin, alpha 1 | −11.85 |
1520461 | CD69 | NM_001781 | CD69 molecule | −28.65 |
1528045 | IL8 | NM_000584 | Interleukin 8 | −35.22 |
1533457 | FCER1A | NM_002001 | Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide | −61.82 |
Cell survival and apoptosis | ||||
1519170 | GADD45A | NM_001924 | Growth arrest and DNA-damage-inducible, alpha | 20.49 |
1531073 | CARD12 | NM_021209 | Caspase recruitment domain family, member 12 | 11.37 |
1513896 | BIRC1 | NM_004536 | Baculoviral IAP repeat-containing 1 | 10.55 |
1525148 | ANXA1 | NM_000700 | Annexin A1 | 7.39 |
1533289 | ANXA3 | NM_005139 | Annexin A3 | 7.33 |
1516682 | CAST | NM_001750 | Calpastatin | 6.97 |
1532823 | PECR | NM_018441 | Peroxisomal trans−2-enoyl-CoA reductase | 5.32 |
1539226 | CARD6 | NM_032587 | Caspase recruitment domain family, member 6 | 5.15 |
1531614 | ELMO2 | NM_022086 | Engulfment and cell motility 2 | 4.67 |
1512780 | LGALS8 | NM_006499 | Lectin, galactoside-binding, soluble, 8 (galectin 8) | 4.24 |
1505831 | CIAS1 | NM_004895 | Cold autoinflammatory syndrome 1 | 4.09 |
1521881 | STK3 | NM_006281 | Serine/threonine kinase 3 (STE20 homolog, yeast) | 3.79 |
1526256 | DDAH2 | NM_013974 | Dimethylarginine dimethylaminohydrolase 2 | 3.75 |
1522394 | TNFRSF10A | NM_003844 | Tumor necrosis factor receptor superfamily, member 10a | 3.69 |
1988846 | AIM1 | NM_001624 | Absent in melanoma 1 | 3.52 |
1509305 | LTB4R | NM_181657 | Leukotriene B4 receptor | 3.20 |
1984749 | HIP1 | BC082970 | Huntingtin interacting protein 1 | 3.19 |
1534293 | LGALS3 | NM_002306 | Lectin, galactoside-binding, soluble, 3 (galectin 3) | 3.03 |
1535837 | SQSTM1 | NM_003900 | Sequestosome 1 | −3.01 |
1537407 | NFKBIE | NM_004556 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | −3.12 |
1987065 | TNFRSF25 | NM_148968 | Homo sapiens tumor necrosis factor receptor superfamily | −3.36 |
1516125 | PRDX2 | NM_005809 | Peroxiredoxin 2 | −3.40 |
1531960 | GSTP1 | NM_000852 | Glutathione S-transferase pi | −3.42 |
1984701 | CARD9 | NM_052813 | Caspase recruitment domain family, member 9 | −3.61 |
1532501 | PIM2 | NM_006875 | Pim−2 oncogene | −3.76 |
1528041 | IL31RA | NM_139017 | Interleukin 31 receptor A | −3.91 |
1533374 | PHLDA2 | NM_003311 | Pleckstrin homology-like domain, family A, member 2 | −3.97 |
1526625 | CARD4 | NM_006092 | Caspase recruitment domain family, member 4 | −3.99 |
1520783 | DYRK2 | NM_006482 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | −4.29 |
1516378 | TNFSF12 | NM_153012 | Tumor necrosis factor (ligand) superfamily, member 12 | −4.29 |
1530737 | LGALS2 | NM_006498 | Lectin, galactoside-binding, soluble, 2 (galectin 2) | −4.47 |
1510435 | LGALS12 | NM_033101 | Lectin, galactoside-binding, soluble, 12 (galectin 12) | −4.47 |
1523074 | HSPA9B | NM_004134 | Heat shock 70-kDa protein 9B (mortalin-2) | −5.16 |
1532326 | DDX58 | NM_014314 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | −5.17 |
1508150 | AOC3 | NM_003734 | Amine oxidase, copper containing 3 (vascular adhesion protein 1) | −5.52 |
1538822 | IFI6 | NM_022873 | Interferon, alpha-inducible protein (clone IFI-6–16) | −5.56 |
1990540 | CLU | NM_203339 | Clusterin | −5.66 |
1517391 | BIRC3 | NM_001165 | Baculoviral IAP repeat-containing 3 | −6.55 |
1538745 | SGK | NM_005627 | Serum/glucocorticoid regulated kinase | −7.90 |
1523311 | BIRC4BP | NM_017523 | XIAP associated factor-1 | −9.09 |
1510278 | NGFRAP1 | NM_014380 | Nerve growth factor receptor (TNFRSF16) associated protein 1 | −9.35 |
1533140 | NME5 | NM_003551 | Non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) | −9.98 |
1533249 | HIG2 | NM_013332 | hypoxia-inducible protein 2 | −15.17 |
Cell adhesion and motility | ||||
1536096 | MMP8 | NM_002424 | Matrix metallopeptidase 8 (neutrophil collagenase) | 97.77 |
1519153 | OLFM4 | NM_006418 | Olfactomedin 4 | 23.81 |
1514453 | CD44 | NM_000610 | CD44 molecule (Indian blood group) | 10.05 |
1532879 | EMILIN2 | NM_032048 | Elastin microfibril interfacer 2 | 9.85 |
1521082 | CEACAM1 | NM_001712 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 5.97 |
1509526 | MMP9 | NM_004994 | Matrix metallopeptidase 9 | 5.64 |
1522658 | VNN1 | NM_004666 | Vanin 1 | 5.35 |
1984856 | ADAM15 | NM_207191 | ADAM metallopeptidase domain 15 (metargidin) | 3.79 |
1507356 | F5 | NM_000130 | Coagulation factor V (proaccelerin, labile factor) | 3.78 |
1516175 | JAK2 | NM_004972 | Janus kinase 2 (a protein tyrosine kinase) | 3.78 |
1508488 | SPP1 | NM_000582 | Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) | 3.72 |
1523771 | ITGAM | NM_000632 | Integrin, alpha M (complement component 3 receptor 3 subunit) | 3.52 |
1508621 | PVRL2 | NM_002856 | Poliovirus receptor-related 2 (herpesvirus entry mediator B) | 3.42 |
1531024 | SIGLEC9 | NM_014441 | Sialic acid binding Ig-like lectin 9 | 3.34 |
1505504 | VIM | NM_003380 | Vimentin | 3.34 |
1986801 | LAMB3 | NM_001017402 | Laminin, beta 3 | 3.11 |
1518582 | CEACAM6 | BC005008 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | −3.07 |
1506966 | SIGLEC8 | NM_014442 | Sialic acid binding immunoglobulin-like lectin 8 | −3.16 |
1534776 | CXCL1 | NM_00–1511 | Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | −3.20 |
1520341 | AZU1 | NM_001700 | Azurocidin 1 (cationic antimicrobial protein 37) | −3.23 |
1520433 | ITGB7 | NM_000889 | Integrin, beta 7 | −3.59 |
1505769 | TUBB1 | NM_030773 | Tubulin, beta 1 | −4.35 |
1528734 | ICAM2 | NM_000873 | Intercellular adhesion molecule 2 | −5.24 |
1991393 | CXCR4 | NM_001008540 | Chemokine (C-X-C motif) receptor 4 | −5.90 |
1989016 | CCL3L3 | NM_001001437 | Chemokine (C-C motif) ligand 3-like 3 | −5.98 |
1510688 | CCL3 | NM_002983 | Chemokine (C-C motif) ligand 3 | −6.35 |
1517696 | CCL5 | NM_002985 | Chemokine (C-C motif) ligand 5 | −7.71 |
1533135 | CXCL10 | NM_001565 | Chemokine (C-X-C motif) ligand 11 | −9.10 |
1505505 | CCL23 | NM_005064 | Chemokine (C-C motif) ligand 23 | −15.06 |
1526404 | CCL4 | NM_002984 | Chemokine (C-C motif) ligand 4 | −15.45 |
1533611 | PPBP | NM_002704 | Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | −16.30 |
1515169 | ITGA4 | NM_000885 | Integrin, alpha 4 (antigen CD49D), alpha 4 subunit of VLA-4 receptor | −16.74 |
1537942 | CCR3 | NM_001837 | Chemokine (C-C motif) receptor 3 | −19.63 |
Cell metabolism | ||||
1538977 | HPGD | NM_000860 | Hydroxyprostaglandin dehydrogenase 15-(NAD) | 36.27 |
1989284 | PFKFB2 | NM_001018053 | 6-phosphofructo-2-kinase/fructose-2.6-biphosphatase 2 | 31.40 |
1986330 | ATP9A | NM_006045 | ATPase, Class II, type 9A | 25.82 |
1511217 | LDHA | NM_005566 | Lactate dehydrogenase A | 10.11 |
1527335 | PCSK9 | NM_174936 | Proprotein convertase subtilisin/kexin type 9 | 7.95 |
1991955 | PLB1 | CR600701 | Phospholipase B1 | 7.59 |
1983476 | ATP13A3 | AJ306929 | ATPase type 13A3 | 7.56 |
1513367 | DPH5 | NM_0–15958 | DPH5 homolog (S cerevisiae) | 6.38 |
1526202 | NMNAT2 | NM_0–15039 | Nicotinamide nucleotide adenylyltransferase 2 | 6.31 |
1536086 | DPYD | NM_000110 | Dihydropyrimidine dehydrogenase | 6.11 |
1990338 | ATP11B | NM_014616 | ATPase, Class VI, type 11B | 6.09 |
1515968 | ALPL | NM_000478 | Alkaline phosphatase, liver/bone/kidney | 5.59 |
1506037 | MGAM | NM_004668 | Maltase-glucoamylase (alpha-glucosidase) | 5.41 |
1532823 | PECR | NM_018441 | Peroxisomal trans-2-enoyl-CoA reductase | 5.32 |
1986414 | ATP2B4 | NM_001001396 | ATPase, Ca2+ transporting, plasma membrane 4 | 4.99 |
1506589 | PFKFB3 | NM_004566 | 6-phosphofructo-2-kinase/fructose-2.6-biphosphatase 3 | 4.75 |
1512399 | AGPAT6 | NM_178819 | 1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta) | 4.74 |
1523383 | PGD | NM_002631 | Phosphogluconate dehydrogenase | 4.70 |
1519383 | ATP6V1C1 | NM_001695 | ATPase, H+ transporting, lysosomal 42 kDa, V1 subunit C1 | 4.11 |
1520655 | SMPDL3A | NM_006714 | Sphingomyelin phosphodiesterase, acid-like 3A | 4.09 |
1989848 | ACSL4 | NM_004458 | Acyl-CoA synthetase long-chain family member 4 | 4.02 |
1522656 | LDLR | NM_000527 | Low-density lipoprotein receptor | 3.63 |
1538541 | DHRS9 | NM_005771 | Dehydrogenase/reductase (SDR family) member 9 | 3.55 |
1514810 | ATP1A3 | NM_152296 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | 3.53 |
1524666 | FABP5 | NM_001444 | Fatty acid binding protein 5 (psoriasis-associated) | 3.38 |
1538372 | ATP1A1 | NM_000701 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | 3.38 |
1524650 | GNS | NM_002076 | Glucosamine (N-acetyl)-6- | 3.37 |
1523432 | ACSL1 | NM_001995 | Acyl-CoA synthetase long-chain family member 1 | 3.35 |
1529572 | SGSH | NM_000199 | N-sulfoglucosamine sulfohydrolase (sulfamidase) | 3.29 |
1538734 | ACSL3 | NM_004457 | Acyl-CoA synthetase long-chain family member 3 | 3.27 |
1985998 | ALOX5 | BQ548663 | Arachidonate 5-lipoxygenase | 3.16 |
1527407 | GAPDH | NM_002046 | Glyceraldehyde3-phosphate dehydrogenase | 3.16 |
1534240 | SULT1B1 | D89479 | Sulfotransferase family, cytosolic, 1B, member 1 | 3.10 |
1983183 | NDUFB6 | NM_182739 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 | −3.10 |
1525237 | ALDH6A1 | NM_005589 | Aldehyde dehydrogenase 6 family, member A1 | −3.22 |
1518778 | ALOX15 | NM_001140 | Arachidonate 15-lipoxygenase | −3.24 |
1523761 | CBR1 | NM_001757 | Carbonyl reductase 1 | −3.61 |
1510672 | MCCC1 | NM_020166 | Methylcrotonoyl-Coenzyme A carboxylase 1 (alpha) | −4.01 |
1990453 | NDUFV2 | BI520375 | NADH dehydrogenase (ubiquinone) flavoprotein 2, 24 kDa | −4.31 |
1521732 | ATP12A | NM_001676 | ATPase, H+/K+ transporting, nongastric, alpha polypeptide | −4.74 |
1526184 | LDHB | NM_002300 | Lactate dehydrogenase B | −6.08 |
1512448 | ISOC1 | NM_016048 | Isochorismatase domain containing 1 | −6.51 |
1989369 | METTL7A | BC004492 | Methyltransferase like 7A | −6.99 |
1518627 | FA2H | NM_024306 | Fatty acid 2-hydroxylase | −7.75 |
1506804 | PLD4 | NM_138790 | Phospholipase D family, member 4 | −9.53 |
1521949 | SORD | NM_003104 | Sorbitol dehydrogenase | −10.20 |
1512822 | SULF2 | NM_018837 | Sulfatase 2 | −21.22 |
Sequence ID . | Primary sequence name . | Sequence code . | Sequence description . | Fold change . |
---|---|---|---|---|
Transcription and regulation of transcription | ||||
1514893 | CCNA1 | NM_003914 | Cyclin A1 | 21.01 |
1983249 | SMARCA3 | BF513730 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 3 | 10.43 |
1513827 | MLXIP | AB020674 | MLX interacting protein | 8.66 |
1519529 | MSL3L1 | NM_078629 | Male-specific lethal 3-like 1 (Drosophila) | 6.75 |
1521872 | MEF2A | NM_005587 | MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A) | 6.47 |
1985292 | ETS2 | BX433326 | V-ets erythroblastosis virus E26 oncogene homolog 2 | 5.59 |
1525013 | BATF | NM_006399 | Basic leucine zipper transcription factor, ATF-like | 5.58 |
1537803 | ENO1 | NM_001428 | Enolase 1, (alpha) | 5.50 |
1533218 | HIPK2 | BC041926 | CDNA clone IMAGE:5300349 | 5.07 |
1522326 | PHTF1 | NM_006608 | Putative homeodomain transcription factor 1 | 4.80 |
1533591 | SIRT5 | NM_012241 | Sirtuin (silent mating type information regulation 2 homolog) 5 (Saccharomyces cerevisiae) | 4.60 |
1512793 | ZNF167 | NM_018651 | Zinc finger protein 167 | 4.30 |
1511846 | PLAG1 | NM_002655 | Pleomorphic adenoma gene 1 | 4.26 |
1512354 | ZNF438 | AK095436 | hypothetical protein LOC220929 | 4.20 |
1507417 | DACH1 | NM_080759 | Dachshund homolog 1 (Drosophila) | 4.04 |
1526663 | ZNF438 | NM_182755 | Zinc finger protein 438 | 4.02 |
1537859 | ZBTB20 | NM_015642 | Zinc finger and BTB domain containing 20 | 3.77 |
1522362 | ZNF658 | NM_033160 | Zinc finger protein 658 | 3.75 |
1534837 | ZNF254 | NM_004876 | Zinc finger protein 539 | 3.73 |
1507368 | CCND3 | NM_001760 | Cyclin D3 | 3.69 |
1509049 | VENTX | NM_014468 | VENT homeobox homolog (Xenopus laevis) | 3.61 |
1985753 | CRTC3 | AK090443 | CREB regulated transcription coactivator 3 | 3.58 |
1529278 | XRN2 | NM_012255 | 5′-3′ exoribonuclease 2 | 3.43 |
1522102 | E2F2 | NM_004091 | E2F transcription factor 2 | 3.36 |
1517472 | CCNC | NM_005190 | Cyclin C | 3.07 |
1535521 | KLF6 | U51869 | Kruppel-like factor 6 | 3.03 |
1537902 | TSC22D1 | NM_183422 | TSC22 domain family, member 1 | −3.01 |
1983175 | MCM7 | NM_182776 | MCM7 minichromosome maintenance deficient | −3.02 |
1529350 | SSRP1 | NM_003146 | Structure specific recognition protein 1 | −3.03 |
1505187 | RELB | NM_006509 | V-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (avian) | −3.04 |
1537144 | DEXI | AK055529 | dexamethasone-induced transcript | −3.07 |
1516882 | MEF2C | NM_002397 | MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) | −3.09 |
1527019 | CHAF1A | NM_005483 | Chromatin assembly factor 1, subunit A (p150) | −3.25 |
1535620 | NCOR2 | NM_006312 | Nuclear receptor co-repressor 2 | −3.34 |
1523857 | ZNF395 | NM_018660 | Zinc finger protein 395 | −3.34 |
1512878 | ZMYND11 | NM_006624 | Zinc finger, MYND domain containing 11 | −3.35 |
1991240 | HMGA1 | NM_145904 | High mobility group AT-hook 1 | −3.37 |
1531990 | HEY1 | NM_012258 | Hairy/enhancer-of-split related with YRPW motif 1 | −3.39 |
1533586 | ELK1 | NM_005229 | ELK1, member of ETS oncogene family | −3.50 |
1515979 | NR4A3 | NM_173199 | Nuclear receptor subfamily 4, group A, member 3 | −3.58 |
1510333 | THRA | NM_003250 | Thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | −3.68 |
1537025 | BTG2 | NM_006763 | BTG family, member 2 | −3.73 |
1513189 | TRERF1 | NM_033502 | Transcriptional regulating factor 1 | −3.76 |
1511905 | JARID2 | NM_004973 | Jumonji, AT-rich interactive domain 2 | −3.81 |
1526826 | ATF3 | NM_004024 | Activating transcription factor 3 | −3.82 |
1523890 | RASSF7 | NM_003475 | Ras association (RalGDS/AF−6) domain family 7 | −3.84 |
1533807 | MAFF | NM_012323 | V-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | −3.89 |
1525862 | JUN | NM_002228 | V-jun sarcoma virus 17 oncogene homolog (avian) | −3.94 |
1507971 | NRL | NM_006177 | Neural retina leucine zipper | −4.09 |
1533916 | LEF1 | NM_016269 | Lymphoid enhancer-binding factor 1 | −4.22 |
1506607 | ASF1B | NM_018154 | ASF1 antisilencing function 1 homolog B (S cerevisiae) | −4.36 |
1509496 | AES | NM_198969 | Amino-terminal enhancer of split | −4.39 |
1533535 | TAF4 | NM_003185 | TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa | −4.40 |
1508056 | EGR3 | NM_004430 | Early growth response 3 | −4.41 |
1533262 | BRF1 | BC016743 | BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S cerevisiae) | −4.48 |
1533571 | PHF6 | NM_032458 | PHD finger protein 6 | −4.53 |
1517506 | EGR2 | NM_000399 | Early growth response 2 (Krox−20 homolog, Drosophila) | −4.66 |
1989375 | SMAD3 | NM_005902 | SMAD, mothers against DPP homolog 3 (Drosophila) | −4.97 |
1507856 | MYB | NM_005375 | V-myb myeloblastosis viral oncogene homolog (avian) | −5.06 |
1528623 | OLIG2 | NM_005806 | Oligodendrocyte lineage transcription factor 2 | −6.11 |
1524585 | GATA1 | NM_002049 | GATA binding protein 1 (globin transcription factor 1) | −6.64 |
1991493 | PARP14 | NM_017554 | Poly (ADP-ribose) polymerase family, member 14 | −7.03 |
1510055 | PCGF5 | BC007377 | Polycomb group ring finger 5 | −7.57 |
1510369 | ASCL2 | NM_005170 | Achaete-scute complex-like 2 (Drosophila) | −7.72 |
1522208 | ZNF584 | NM_173548 | Zinc finger protein 584 | −7.93 |
1523937 | RPS6KA5 | NM_004755 | Ribosomal protein S6 kinase, 90 kDa, polypeptide 5 | −8.07 |
1529851 | ETV7 | NM_016135 | Ets variant gene 7 (TEL2 oncogene) | −8.56 |
1506298 | GATA6 | NM_005257 | GATA binding protein 6 | −8.65 |
1989096 | SSBP3 | NM_001009955 | Single stranded DNA binding protein 3 | −8.76 |
1520503 | NKX31 | NM_006167 | NK3 transcription factor related, locus 1 (Drosophila) | −9.56 |
1522991 | ZNF649 | NM_023074 | Zinc finger protein 649 | −11.07 |
1514700 | NR4A1 | NM_002135 | Nuclear receptor subfamily 4, group A, member 1 | −92.91 |
Signal transduction | ||||
1513543 | GPR84 | NM_020370 | G protein-coupled receptor 84 | 25.51 |
1505483 | EDG1 | NM_001400 | Endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 | 18.05 |
1511321 | PTGER2 | NM_000956 | Prostaglandin E receptor 2 (subtype EP2), 53 kDa | 8.26 |
1511570 | ARHGAP24 | AK130576 | Rho GTPase activating protein 24 | 7.28 |
1523886 | PDE4D | NM_006203 | Phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila) | 6.64 |
1527053 | MYO10 | BC041694 | Myosin X | 6.48 |
1512860 | MS4A4A | NM_024021 | Membrane-spanning 4-domains, subfamily A, member 4 | 6.12 |
1539087 | DLC1 | NM_182643 | Deleted in liver cancer 1 | 5.96 |
1528643 | MS4A6A | NM_022349 | Membrane-spanning 4-domains, subfamily A, member 6A | 5.87 |
1524040 | GPR141 | NM_181791 | G protein-coupled receptor 141 | 5.28 |
1989101 | EDARADD | NM_080738 | EDAR-associated death domain | 4.64 |
1508615 | EXT1 | NM_000127 | Exostoses (multiple) 1 | 4.30 |
1521881 | STK3 | NM_006281 | Serine/threonine kinase 3 (STE20 homolog, yeast) | 3.79 |
1510158 | ITPKC | NM_025194 | Inositol 1.4,5-trisphosphate 3-kinase C | 3.63 |
1519571 | CDC42EP3 | NM_006449 | CDC42 effector protein (Rho GTPase binding) 3 | 3.58 |
1534557 | DPYSL3 | NM_001387 | Dihydropyrimidinase-like 3 | 3.54 |
1536781 | RPS6KA3 | NM_004586 | Ribosomal protein S6 kinase, 90 kDa, polypeptide 3 | 3.53 |
1533999 | HHIP | NM_022475 | Hedgehog interacting protein | 3.50 |
1512578 | GPR97 | NM_170776 | G protein-coupled receptor 97 | 3.42 |
1514738 | SLC26A6 | NM_022911 | Inositol hexaphosphate kinase 2 | 3.28 |
1517434 | IL4R | NM_000418 | Interleukin 4 receptor | 3.21 |
1539209 | GABBR1 | NM_001470 | Gamma-aminobutyric acid (GABA) B receptor, 1 | 3.19 |
1511435 | STK16 | NM_003691 | Serine/threonine kinase 16 | 3.17 |
1520958 | PRKAR2A | BC002763 | Inositol hexaphosphate kinase 2 | 3.12 |
1506387 | MAPK6 | NM_002748 | Mitogen-activated protein kinase 6 | 3.03 |
1523162 | ITPK1 | NM_014216 | Inositol 1.3,4-triphosphate 5/6 kinase | −3.05 |
1507956 | GNGT2 | NM_031498 | Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 | −3.09 |
1514326 | TAGAP | NM_138810 | T-cell activation GTPase activating protein | −3.09 |
1530414 | GPR171 | NM_013308 | G protein-coupled receptor 171 | −3.16 |
1527339 | P2RY5 | NM_005767 | Purinergic receptor P2Y, G-protein coupled, 5 | −3.17 |
1517355 | ARHGAP25 | BC039591 | Rho GTPase activating protein 25 | −3.23 |
1520830 | KIT | NM_000222 | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | −3.28 |
1517660 | KLRK1 | NM_007360 | Killer cell lectin-like receptor subfamily C, member 4 | −3.37 |
1514077 | KLRB1 | NM_002258 | Killer cell lectin-like receptor subfamily B, member 1 | −3.43 |
1518328 | GRP | NM_002091 | Gastrin-releasing peptide | −3.64 |
1516849 | EPHB1 | NM_004441 | EPH receptor B1 | −3.80 |
1514753 | PRKAG2 | NM_016203 | Protein kinase, AMP-activated, gamma 2 non-catalytic subunit | −4.09 |
1512127 | SOCS1 | NM_003745 | Suppressor of cytokine signaling 1 | −4.13 |
1518864 | FLT3LG | NM_001459 | Fms-related tyrosine kinase 3 ligand | −4.26 |
1524915 | OR51E1 | NM_152430 | Olfactory receptor, family 51, subfamily E, member 1 | −4.27 |
1507227 | P2RY14 | NM_014879 | Purinergic receptor P2Y, G-protein coupled, 14 | −4.28 |
1523084 | GUCA1A | NM_000409 | Guanylate cyclase activator 1A (retina) | −4.37 |
1525046 | PILRA | NM_178273 | Paired immunoglobulin-like type 2 receptor alpha | −4.48 |
1534223 | PPP1R12B | NM_032105 | Protein phosphatase 1, regulatory (inhibitor) subunit 12B | −4.66 |
1518048 | GPR34 | NM_005300 | G-protein–coupled receptor 34 | −4.78 |
1534320 | ARRB1 | NM_004041 | Arrestin, beta 1 | −5.02 |
1534974 | KLRD1 | NM_002262 | Killer cell lectin-like receptor subfamily D, member 1 | −5.16 |
1525314 | S100A10 | NM_002966 | S100 calcium binding protein A10 | −5.94 |
1530940 | PRKAR2B | NM_002736 | Protein kinase, cAMP-dependent, regulatory, type II, beta | −5.97 |
1522410 | IL2RB | NM_000878 | Interleukin 2 receptor, beta | −6.06 |
1518652 | CD74 | NM_004355 | CD74 molecule, major histocompatibility complex, class II invariant chain | −6.23 |
1515002 | CYSLTR1 | NM_006639 | Cysteinyl leukotriene receptor 1 | −6.45 |
1530332 | MX1 | NM_002462 | Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | −6.76 |
1522509 | OR2B2 | NM_033057 | Olfactory receptor, family 2, subfamily B, member 2 | −6.88 |
1984459 | PDE4B | AB209081 | Phosphodiesterase 4B, cAMP-specific | −6.89 |
1527378 | CSF1R | NM_005211 | Colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog | −7.08 |
1527858 | NRGN | NM_006176 | Neurogranin (protein kinase C substrate, RC3) | −7.49 |
1524392 | ANGPT1 | NM_001146 | Angiopoietin 1 | −8.84 |
1516837 | MS4A3 | NM_006138 | Membrane-spanning 4-domains, subfamily A, member 3 | −9.24 |
1989999 | IL5RA | NM_175725 | Interleukin 5 receptor, alpha | −9.66 |
1524637 | GPR162 | NM_019858 | Triosephosphate isomerase 1 | −10.10 |
1519217 | P2RY2 | NM_176072 | Purinergic receptor P2Y, G-protein coupled, 2 | −11.66 |
1516830 | P2RY10 | NM_014499 | Purinergic receptor P2Y, G-protein coupled, 10 | −11.67 |
1518123 | CD83 | NM_004233 | CD83 molecule | −11.67 |
1517216 | KLRF1 | NM_016523 | Killer cell lectin-like receptor subfamily F, member 1 | −12.68 |
1512228 | EBI2 | NM_004951 | Epstein-Barr virus–induced gene 2 (lymphocyte-specific G protein-coupled receptor) | −13.11 |
1513158 | HRH4 | NM_021624 | Histamine receptor H4 | −13.66 |
1537338 | FGL2 | NM_006682 | Fibrinogen-like 2 | −13.76 |
1515714 | GNG11 | NM_004126 | Guanine nucleotide binding protein (G protein), gamma 11 | −16.57 |
1527111 | GPR44 | NM_004778 | G protein-coupled receptor 44 | −23.51 |
1528909 | RGS1 | NM_002922 | Regulator of G-protein signaling 1 | −32.65 |
Immune responses | ||||
1507161 | CD163 | NM_004244 | CD163 molecule | 54.27 |
1531927 | CYP1B1 | NM_000104 | Cytochrome P450, family 1, subfamily B, polypeptide 1 | 46.19 |
1984958 | CD177 | CR592446 | CD177 molecule | 24.38 |
1521404 | IL18R1 | NM_003855 | Interleukin 18 receptor 1 | 16.54 |
1983056 | MERTK | U08023 | C-mer proto-oncogene tyrosine kinase | 16.00 |
1532739 | CLEC5A | NM_013252 | C-type lectin domain family 5, member A | 13.44 |
1511835 | CLEC4D | NM_080387 | C-type lectin domain family 4, member D | 12.02 |
1535646 | CST7 | NM_003650 | Cystatin F (leukocystatin) | 11.43 |
1506996 | ADORA3 | NM_020683 | Adenosine A3 receptor | 10.89 |
1530098 | IL18RAP | NM_003853 | Interleukin 18 receptor accessory protein | 10.79 |
1532148 | LAIR1 | NM_021706 | Leukocyte-associated immunoglobulin-like receptor 1 | 10.45 |
1506562 | HP | NM_005143 | Haptoglobin | 10.31 |
1505718 | IL1R2 | NM_004633 | Interleukin 1 receptor, type II | 9.95 |
1507483 | LILRA5 | NM_181879 | Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | 7.56 |
1524454 | XBP1 | NM_005080 | X-box binding protein 1 | 7.48 |
1510813 | IRAK3 | NM_007199 | Interleukin−1 receptor-associated kinase 3 | 7.28 |
1538778 | TLR5 | NM_003268 | Toll-like receptor 5 | 5.97 |
1521047 | CR1 | NM_000651 | Complement component (3b/4b) receptor 1 (Knops blood group) | 5.87 |
1520792 | MAPK14 | NM_139013 | Mitogen-activated protein kinase 14 | 5.75 |
1535716 | CD59 | NM_203330 | CD59 molecule, complement regulatory protein | 5.67 |
1513648 | FCER1G | CB529629 | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 5.26 |
1521687 | TLR4 | BF670973 | Toll-like receptor 4 | 5.15 |
1530114 | MAP2K6 | NM_002758 | Mitogen-activated protein kinase kinase 6 | 4.87 |
1533789 | SERPINB1 | NM_030666 | Serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 4.84 |
1522193 | FCAR | NM_002000 | Fc fragment of IgA, receptor for | 4.52 |
1527121 | PROK2 | NM_021935 | Prokineticin 2 | 4.33 |
1505831 | CIAS1 | NM_004895 | Cold autoinflammatory syndrome 1 | 4.09 |
1524842 | IL10 | NM_000572 | Interleukin 10 | 3.89 |
1538909 | IL1RAP | NM_002182 | Interleukin 1 receptor accessory protein | 3.80 |
1506853 | CHIT1 | NM_003465 | Chitinase 1 (chitotriosidase) | 3.48 |
1531091 | CD55 | NM_000574 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 3.39 |
1534101 | IL1R1 | NM_000877 | Interleukin 1 receptor, type I | 3.34 |
1515424 | CYBB | S67289 | Cytochrome b-245, beta polypeptide (chronic granulomatous disease) | 3.29 |
1985998 | ALOX5 | BQ548663 | Arachidonate 5-lipoxygenase | 3.16 |
1510372 | IRAK4 | NM_016123 | Interleukin-1 receptor-associated kinase 4 | 3.10 |
1514172 | CD48 | NM_001778 | CD48 molecule | 3.09 |
1527340 | TLR8 | NM_016610 | Toll-like receptor 8 | 3.07 |
1511452 | SERPING1 | NM_000062 | Serpin peptidase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary) | −3.00 |
1530131 | IRF2BP2 | BC020516 | Interferon regulatory factor 2 binding protein 2 | −3.03 |
1512742 | CLEC7A | NM_197954 | C-type lectin domain family 7, member A | −3.06 |
1528251 | NCR3 | NM_147130 | Natural cytotoxicity triggering receptor 3 | −3.13 |
1513772 | HLA-DRB3 | NM_022555 | Major histocompatibility complex, class II, DR beta 1 | −3.17 |
1518778 | ALOX15 | NM_001140 | Arachidonate 15-lipoxygenase | −3.24 |
1524640 | OAS3 | NM_006187 | 2'−5'-oligoadenylate synthetase 3, 100 kDa | −3.31 |
1985491 | HLA-DRB1 | X12544 | Major histocompatibility complex, class II, DR beta 1 | −3.31 |
1519302 | STAT1 | NM_139266 | Signal transducer and activator of transcription 1, 91 kDa | −3.39 |
1509654 | CTSW | NM_001335 | Cathepsin W (lymphopain) | −3.45 |
1992017 | PLAUR | NM_001005377 | Plasminogen activator, urokinase receptor | −3.50 |
1526588 | LY75 | NM_002349 | Lymphocyte antigen 75 | −3.51 |
1536508 | LST1 | NM_007161 | Leukocyte specific transcript 1 | −3.64 |
1515890 | FAIM3 | NM_005449 | Interleukin 24 | −3.65 |
1511424 | EMR3 | NM_032571 | Egf-like module containing, mucin-like, hormone receptor-like 3 | −3.71 |
1534340 | CD46 | NM_002389 | CD46 molecule, complement regulatory protein | −3.83 |
1537056 | GBP3 | NM_018284 | Guanylate binding protein 1, interferon-inducible, 67 kDa | −3.86 |
1517555 | CYP27A1 | NM_000784 | Cytochrome P450, family 27, subfamily A, polypeptide 1 | −3.88 |
1516190 | SAMHD1 | NM_015474 | SAM domain and HD domain 1 | −3.89 |
1519488 | HLA-DQB2 | NM_182549 | Major histocompatibility complex, class II, DQ beta 2 | −3.94 |
1983904 | IL32 | NM_001012631 | Interleukin 32 | −3.99 |
1505541 | GZMB | NM_004131 | Granzyme B | −4.04 |
1536691 | GZMK | NM_002104 | Granzyme K (granzyme 3; tryptase II) | −4.67 |
1522713 | GZMA | NM_006144 | Granzyme A | −4.80 |
1510975 | HLA-DRB5 | NM_002125 | Major histocompatibility complex, class II, DR beta 1 | −5.13 |
1527466 | HLA-DPA1 | NM_033554 | Major histocompatibility complex, class II, DP alpha 1 | −5.16 |
1516918 | B2M | AK022379 | Beta−2-microglobulin | −5.43 |
1538818 | HLA-DQB1 | NM_002123 | Major histocompatibility complex, class II, DQ beta 1 | −5.87 |
1521122 | SPON2 | NM_012445 | Spondin 2, extracellular matrix protein | −5.95 |
1517271 | PF4V1 | NM_002620 | Platelet factor 4 variant 1 | −6.48 |
1508682 | HLA-DPB1 | NM_002121 | Major histocompatibility complex, class II, DP beta 1 | −6.67 |
1529151 | OASL | NM_003733 | 2′−5′-oligoadenylate synthetase-like | −7.10 |
1987518 | CYB561 | NM_001017916 | Cytochrome b-561 | −7.39 |
1524314 | IFI44 | NM_006417 | Interferon-induced protein 44 | −7.91 |
1533656 | DEFA4 | NM_001925 | Defensin, alpha 4, corticostatin | −9.04 |
1526794 | HLA-DRA | NM_019111 | Major histocompatibility complex, class II, DR alpha | −10.12 |
1536919 | HLA-DMB | NM_002118 | Major histocompatibility complex, class II, DM beta | −10.73 |
1525510 | PF4 | NM_002619 | Platelet factor 4 (chemokine (C-X-C motif) ligand 4) | −11.03 |
1514544 | DEFA3 | NM_005217 | Defensin, alpha 1 | −11.85 |
1520461 | CD69 | NM_001781 | CD69 molecule | −28.65 |
1528045 | IL8 | NM_000584 | Interleukin 8 | −35.22 |
1533457 | FCER1A | NM_002001 | Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide | −61.82 |
Cell survival and apoptosis | ||||
1519170 | GADD45A | NM_001924 | Growth arrest and DNA-damage-inducible, alpha | 20.49 |
1531073 | CARD12 | NM_021209 | Caspase recruitment domain family, member 12 | 11.37 |
1513896 | BIRC1 | NM_004536 | Baculoviral IAP repeat-containing 1 | 10.55 |
1525148 | ANXA1 | NM_000700 | Annexin A1 | 7.39 |
1533289 | ANXA3 | NM_005139 | Annexin A3 | 7.33 |
1516682 | CAST | NM_001750 | Calpastatin | 6.97 |
1532823 | PECR | NM_018441 | Peroxisomal trans−2-enoyl-CoA reductase | 5.32 |
1539226 | CARD6 | NM_032587 | Caspase recruitment domain family, member 6 | 5.15 |
1531614 | ELMO2 | NM_022086 | Engulfment and cell motility 2 | 4.67 |
1512780 | LGALS8 | NM_006499 | Lectin, galactoside-binding, soluble, 8 (galectin 8) | 4.24 |
1505831 | CIAS1 | NM_004895 | Cold autoinflammatory syndrome 1 | 4.09 |
1521881 | STK3 | NM_006281 | Serine/threonine kinase 3 (STE20 homolog, yeast) | 3.79 |
1526256 | DDAH2 | NM_013974 | Dimethylarginine dimethylaminohydrolase 2 | 3.75 |
1522394 | TNFRSF10A | NM_003844 | Tumor necrosis factor receptor superfamily, member 10a | 3.69 |
1988846 | AIM1 | NM_001624 | Absent in melanoma 1 | 3.52 |
1509305 | LTB4R | NM_181657 | Leukotriene B4 receptor | 3.20 |
1984749 | HIP1 | BC082970 | Huntingtin interacting protein 1 | 3.19 |
1534293 | LGALS3 | NM_002306 | Lectin, galactoside-binding, soluble, 3 (galectin 3) | 3.03 |
1535837 | SQSTM1 | NM_003900 | Sequestosome 1 | −3.01 |
1537407 | NFKBIE | NM_004556 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | −3.12 |
1987065 | TNFRSF25 | NM_148968 | Homo sapiens tumor necrosis factor receptor superfamily | −3.36 |
1516125 | PRDX2 | NM_005809 | Peroxiredoxin 2 | −3.40 |
1531960 | GSTP1 | NM_000852 | Glutathione S-transferase pi | −3.42 |
1984701 | CARD9 | NM_052813 | Caspase recruitment domain family, member 9 | −3.61 |
1532501 | PIM2 | NM_006875 | Pim−2 oncogene | −3.76 |
1528041 | IL31RA | NM_139017 | Interleukin 31 receptor A | −3.91 |
1533374 | PHLDA2 | NM_003311 | Pleckstrin homology-like domain, family A, member 2 | −3.97 |
1526625 | CARD4 | NM_006092 | Caspase recruitment domain family, member 4 | −3.99 |
1520783 | DYRK2 | NM_006482 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | −4.29 |
1516378 | TNFSF12 | NM_153012 | Tumor necrosis factor (ligand) superfamily, member 12 | −4.29 |
1530737 | LGALS2 | NM_006498 | Lectin, galactoside-binding, soluble, 2 (galectin 2) | −4.47 |
1510435 | LGALS12 | NM_033101 | Lectin, galactoside-binding, soluble, 12 (galectin 12) | −4.47 |
1523074 | HSPA9B | NM_004134 | Heat shock 70-kDa protein 9B (mortalin-2) | −5.16 |
1532326 | DDX58 | NM_014314 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | −5.17 |
1508150 | AOC3 | NM_003734 | Amine oxidase, copper containing 3 (vascular adhesion protein 1) | −5.52 |
1538822 | IFI6 | NM_022873 | Interferon, alpha-inducible protein (clone IFI-6–16) | −5.56 |
1990540 | CLU | NM_203339 | Clusterin | −5.66 |
1517391 | BIRC3 | NM_001165 | Baculoviral IAP repeat-containing 3 | −6.55 |
1538745 | SGK | NM_005627 | Serum/glucocorticoid regulated kinase | −7.90 |
1523311 | BIRC4BP | NM_017523 | XIAP associated factor-1 | −9.09 |
1510278 | NGFRAP1 | NM_014380 | Nerve growth factor receptor (TNFRSF16) associated protein 1 | −9.35 |
1533140 | NME5 | NM_003551 | Non-metastatic cells 5, protein expressed in (nucleoside-diphosphate kinase) | −9.98 |
1533249 | HIG2 | NM_013332 | hypoxia-inducible protein 2 | −15.17 |
Cell adhesion and motility | ||||
1536096 | MMP8 | NM_002424 | Matrix metallopeptidase 8 (neutrophil collagenase) | 97.77 |
1519153 | OLFM4 | NM_006418 | Olfactomedin 4 | 23.81 |
1514453 | CD44 | NM_000610 | CD44 molecule (Indian blood group) | 10.05 |
1532879 | EMILIN2 | NM_032048 | Elastin microfibril interfacer 2 | 9.85 |
1521082 | CEACAM1 | NM_001712 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 5.97 |
1509526 | MMP9 | NM_004994 | Matrix metallopeptidase 9 | 5.64 |
1522658 | VNN1 | NM_004666 | Vanin 1 | 5.35 |
1984856 | ADAM15 | NM_207191 | ADAM metallopeptidase domain 15 (metargidin) | 3.79 |
1507356 | F5 | NM_000130 | Coagulation factor V (proaccelerin, labile factor) | 3.78 |
1516175 | JAK2 | NM_004972 | Janus kinase 2 (a protein tyrosine kinase) | 3.78 |
1508488 | SPP1 | NM_000582 | Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) | 3.72 |
1523771 | ITGAM | NM_000632 | Integrin, alpha M (complement component 3 receptor 3 subunit) | 3.52 |
1508621 | PVRL2 | NM_002856 | Poliovirus receptor-related 2 (herpesvirus entry mediator B) | 3.42 |
1531024 | SIGLEC9 | NM_014441 | Sialic acid binding Ig-like lectin 9 | 3.34 |
1505504 | VIM | NM_003380 | Vimentin | 3.34 |
1986801 | LAMB3 | NM_001017402 | Laminin, beta 3 | 3.11 |
1518582 | CEACAM6 | BC005008 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | −3.07 |
1506966 | SIGLEC8 | NM_014442 | Sialic acid binding immunoglobulin-like lectin 8 | −3.16 |
1534776 | CXCL1 | NM_00–1511 | Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | −3.20 |
1520341 | AZU1 | NM_001700 | Azurocidin 1 (cationic antimicrobial protein 37) | −3.23 |
1520433 | ITGB7 | NM_000889 | Integrin, beta 7 | −3.59 |
1505769 | TUBB1 | NM_030773 | Tubulin, beta 1 | −4.35 |
1528734 | ICAM2 | NM_000873 | Intercellular adhesion molecule 2 | −5.24 |
1991393 | CXCR4 | NM_001008540 | Chemokine (C-X-C motif) receptor 4 | −5.90 |
1989016 | CCL3L3 | NM_001001437 | Chemokine (C-C motif) ligand 3-like 3 | −5.98 |
1510688 | CCL3 | NM_002983 | Chemokine (C-C motif) ligand 3 | −6.35 |
1517696 | CCL5 | NM_002985 | Chemokine (C-C motif) ligand 5 | −7.71 |
1533135 | CXCL10 | NM_001565 | Chemokine (C-X-C motif) ligand 11 | −9.10 |
1505505 | CCL23 | NM_005064 | Chemokine (C-C motif) ligand 23 | −15.06 |
1526404 | CCL4 | NM_002984 | Chemokine (C-C motif) ligand 4 | −15.45 |
1533611 | PPBP | NM_002704 | Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | −16.30 |
1515169 | ITGA4 | NM_000885 | Integrin, alpha 4 (antigen CD49D), alpha 4 subunit of VLA-4 receptor | −16.74 |
1537942 | CCR3 | NM_001837 | Chemokine (C-C motif) receptor 3 | −19.63 |
Cell metabolism | ||||
1538977 | HPGD | NM_000860 | Hydroxyprostaglandin dehydrogenase 15-(NAD) | 36.27 |
1989284 | PFKFB2 | NM_001018053 | 6-phosphofructo-2-kinase/fructose-2.6-biphosphatase 2 | 31.40 |
1986330 | ATP9A | NM_006045 | ATPase, Class II, type 9A | 25.82 |
1511217 | LDHA | NM_005566 | Lactate dehydrogenase A | 10.11 |
1527335 | PCSK9 | NM_174936 | Proprotein convertase subtilisin/kexin type 9 | 7.95 |
1991955 | PLB1 | CR600701 | Phospholipase B1 | 7.59 |
1983476 | ATP13A3 | AJ306929 | ATPase type 13A3 | 7.56 |
1513367 | DPH5 | NM_0–15958 | DPH5 homolog (S cerevisiae) | 6.38 |
1526202 | NMNAT2 | NM_0–15039 | Nicotinamide nucleotide adenylyltransferase 2 | 6.31 |
1536086 | DPYD | NM_000110 | Dihydropyrimidine dehydrogenase | 6.11 |
1990338 | ATP11B | NM_014616 | ATPase, Class VI, type 11B | 6.09 |
1515968 | ALPL | NM_000478 | Alkaline phosphatase, liver/bone/kidney | 5.59 |
1506037 | MGAM | NM_004668 | Maltase-glucoamylase (alpha-glucosidase) | 5.41 |
1532823 | PECR | NM_018441 | Peroxisomal trans-2-enoyl-CoA reductase | 5.32 |
1986414 | ATP2B4 | NM_001001396 | ATPase, Ca2+ transporting, plasma membrane 4 | 4.99 |
1506589 | PFKFB3 | NM_004566 | 6-phosphofructo-2-kinase/fructose-2.6-biphosphatase 3 | 4.75 |
1512399 | AGPAT6 | NM_178819 | 1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta) | 4.74 |
1523383 | PGD | NM_002631 | Phosphogluconate dehydrogenase | 4.70 |
1519383 | ATP6V1C1 | NM_001695 | ATPase, H+ transporting, lysosomal 42 kDa, V1 subunit C1 | 4.11 |
1520655 | SMPDL3A | NM_006714 | Sphingomyelin phosphodiesterase, acid-like 3A | 4.09 |
1989848 | ACSL4 | NM_004458 | Acyl-CoA synthetase long-chain family member 4 | 4.02 |
1522656 | LDLR | NM_000527 | Low-density lipoprotein receptor | 3.63 |
1538541 | DHRS9 | NM_005771 | Dehydrogenase/reductase (SDR family) member 9 | 3.55 |
1514810 | ATP1A3 | NM_152296 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | 3.53 |
1524666 | FABP5 | NM_001444 | Fatty acid binding protein 5 (psoriasis-associated) | 3.38 |
1538372 | ATP1A1 | NM_000701 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | 3.38 |
1524650 | GNS | NM_002076 | Glucosamine (N-acetyl)-6- | 3.37 |
1523432 | ACSL1 | NM_001995 | Acyl-CoA synthetase long-chain family member 1 | 3.35 |
1529572 | SGSH | NM_000199 | N-sulfoglucosamine sulfohydrolase (sulfamidase) | 3.29 |
1538734 | ACSL3 | NM_004457 | Acyl-CoA synthetase long-chain family member 3 | 3.27 |
1985998 | ALOX5 | BQ548663 | Arachidonate 5-lipoxygenase | 3.16 |
1527407 | GAPDH | NM_002046 | Glyceraldehyde3-phosphate dehydrogenase | 3.16 |
1534240 | SULT1B1 | D89479 | Sulfotransferase family, cytosolic, 1B, member 1 | 3.10 |
1983183 | NDUFB6 | NM_182739 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 | −3.10 |
1525237 | ALDH6A1 | NM_005589 | Aldehyde dehydrogenase 6 family, member A1 | −3.22 |
1518778 | ALOX15 | NM_001140 | Arachidonate 15-lipoxygenase | −3.24 |
1523761 | CBR1 | NM_001757 | Carbonyl reductase 1 | −3.61 |
1510672 | MCCC1 | NM_020166 | Methylcrotonoyl-Coenzyme A carboxylase 1 (alpha) | −4.01 |
1990453 | NDUFV2 | BI520375 | NADH dehydrogenase (ubiquinone) flavoprotein 2, 24 kDa | −4.31 |
1521732 | ATP12A | NM_001676 | ATPase, H+/K+ transporting, nongastric, alpha polypeptide | −4.74 |
1526184 | LDHB | NM_002300 | Lactate dehydrogenase B | −6.08 |
1512448 | ISOC1 | NM_016048 | Isochorismatase domain containing 1 | −6.51 |
1989369 | METTL7A | BC004492 | Methyltransferase like 7A | −6.99 |
1518627 | FA2H | NM_024306 | Fatty acid 2-hydroxylase | −7.75 |
1506804 | PLD4 | NM_138790 | Phospholipase D family, member 4 | −9.53 |
1521949 | SORD | NM_003104 | Sorbitol dehydrogenase | −10.20 |
1512822 | SULF2 | NM_018837 | Sulfatase 2 | −21.22 |
Genes that were found to be differentially expressed after in vivo treatment with G-CSF-dexamethasone were analyzed with use of the OntoExpress program (http://vortex.cs.wayne.edu/projects.htm#Onto-Express), and categorized into functional profiles. The majority of analyzed genes are categorized into 6 main functional categories: transcription, signal transduction, immune response, cell faith & apoptosis, cell adhesion and mobility, and metabolism. Results are presented as the mean fold-increase or -decrease of 3 separate donors (comparison is with freshly isolated neutrophils t = 0).